Hitachi Healthcare Americas Unveils the Latest in Cardiovascular Ultrasound and Reporting at ASE 2018

Twinsburg, Ohio, June 15, 2018 - Hitachi Healthcare Americas will be demonstrating its latest technologies at ASE 2018 in Nashville, Tennessee, June 23 - 25. Committed to delivering solutions that help providers meet new challenges, Hitachi’s bed-to-the-report workflow sets a new standard for integrated solutions.

The Lisendo 880, Hitachi’s premium 2D/3D diagnostic ultrasound solution delivers high quality imaging for your cardiovascular patients in any clinical setting. A true one-system solution for adult, fetal, pediatric and congenital patients, Lisendo 880 boasts HDAnalytics advanced analysis, HemoDynamic Structural Intelligence, an AI fueled automation workflow, and clinical reporting analytics. Lisendo 880 redefines the vision for cardiovascular ultrasound.

Integrated with the Lisendo 880 is VidiStar, Hitachi’s cloud-based cardiac image management and analytics platform enabling physicians to create value-based reports. As clients move towards value-based care, VidiStar can help them navigate the transition successfully:

  • with cloud-based solutions, that efficiently deploy and adopt technology across complex and diverse organizations
  • with structured reporting, that standardizes and improves the quality of clinical reports and streamlines communication, reducing errors and turn-around time
  • with advanced analytics and data mining, that identifies key value drivers and improves decision making

We invite everyone attending ASE to Hitachi’s IMAGINGINSIDERS Science and Technology Theater: 3D Imaging & Diagnostics. Join us for an evening of educational presentations, dinner, drinks and music.
 

Saturday, June 23, 6:30PM

Flow & Function Relationship in Health & Disease Impact of 3D: Changing Perspectives

Dr. Partho Sengupta, MD, MBBS, FACC, FASE Lissa Sugeng, MD, MPH, FACC, FASE West Virginia University Hospital Yale New Haven Hospital. 

Visit Booth 606 for a demo or to learn more. 

 

ABOUT HITACHI HEALTHCARE AMERICAS

Hitachi Healthcare Americas delivers best in class medical imaging technologies for healthcare providers. Hitachi’s MRI, CT and Ultrasound along with Agfa HealthCare’s Digital Radiology provide speed, comfort and quality for both physicians and patients and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Hitachi’s VidiStar image and reporting platform enables healthcare professionals to create value-based reports leveraging a cloud-based image management and analytics platform for improved communication across the healthcare organization. Physicians can grow their business into pediatrics, orthopedics and other unique patient populations while exploring new areas to compete. With an optimized and patient centric approach healthcare providers can deliver strong value into their communities and Hitachi will be there to support them. Our customer first philosophy compels us to make customer support one of the most important things we do. Innovating Healthcare, Embracing the Future. www.hitachihealthcare.com

 

ABOUT HITACHI, LTD.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges, combining its operational technology, information technology, and products/systems. The company’s consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup